Affordable Access

Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas

Authors
Journal
Molecular Cancer Therapeutics
1535-7163
Publisher
American Association for Cancer Research
Publication Date
Disciplines
  • Biology
  • Chemistry
  • Medicine

Abstract

Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas RESEARCH Open Access Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas Juan P Rodrigo1*, Dario García-Carracedo1, María V González1, Gonzalo Mancebo1, Manuel F Fresno2, Juana García-Pedrero1 Abstract Background: Podoplanin expression is attracting interest as a marker for cancer diagnosis and prognosis. We therefore investigated the expression pattern and clinical significance of podoplanin during the development and progression of laryngeal carcinomas. Results: Podoplanin expression was determined by immunohistochemistry in paraffin-embedded tissue specimens from 84 patients with laryngeal premalignancies and 53 patients with laryngeal squamous cell carcinomas. We found podoplanin expression extending from the basal to the suprabasal layer of the epithelium in 37 (44%) of 84 dysplastic lesions, whereas normal epithelium showed negligible expression. Patients carrying podoplanin-positive lesions had a higher laryngeal cancer incidence than those with negative expression reaching borderline statistical significance (51% versus 30%, P = 0.071). Podoplanin expression in laryngeal carcinomas exhibited two distinct patterns. 20 (38%) cases showed diffuse expression in most tumour cells and 33 (62%) focal expression at the proliferating periphery of tumour nests. High podoplanin expression was inversely correlated with T classification (P = 0.033), disease stage (P = 0.006), and pathological grade (P = 0.04). There was a trend, although not significant, towards reduced disease-specific survival for patients with low podoplanin levels (P = 0.31) and diffuse expression pattern (P = 0.08). Conclusions: Podoplanin expression increases in the early stages of laryngeal tumourigenesis and it seems to be associated with a higher laryngeal cancer risk. Podoplanin expression in laryngeal squamous cell carcinomas, however, diminishes during tumour progressio

There are no comments yet on this publication. Be the first to share your thoughts.